title: Infection in OKT3-treated patients receiving additional antirejection therapy.
authors.affiliation: Department of Surgery, University of Cincinnati College of Medicine, Ohio 45267-0558.
authors.forename: R
authors.initials: R
authors.lastname: Munda
authors.forename: M
authors.initials: M
authors.lastname: Hutchins
authors.forename: M R
authors.initials: MR
authors.lastname: First
authors.forename: M
authors.initials: M
authors.lastname: Carey
authors.forename: T
authors.initials: T
authors.lastname: Schroeder
authors.forename: J W
authors.initials: JW
authors.lastname: Alexander
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology*; D002177:Candidiasis / Q000209:etiology; D002986:Clinical Trials as Topic; D005260:Female; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008297:Male; D014777:Virus Diseases / Q000209:etiology*
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents